Screening of Newer Phytoconstituents on Novel Enzymes for their Biological Activity

Year : 2025 | Volume : 16 | Issue : 01 | Page : 81 86
    By

    Mukund DW,

  • Natarajan. K,

  • Vineeth Chandy,

  1. Research Scholar, Department of Pharmaceutical Biotechnology, T. John College of Pharmacy, Bangalore, Karnataka, India
  2. Associate Professor, Department of Pharmaceutical Biotechnology, T. John College of Pharmacy, Bangalore, Karnataka, India
  3. Principal, T. John College of Pharmacy, Bangalore, Karnataka, India

Abstract

Background: Hyperlipidemia and gout are prevalent metabolic disorders significantly impacting global health. The xanthine oxidase and HMG-CoA reductase pathways play pivotal roles in the pathophysiology of these conditions. This study explores the potential of natural phytoconstituents—daidzein, resveratrol, and genistein—as dual inhibitors for these enzymatic targets, offering insights into innovative therapeutic strategies. Aim: To evaluate the potential of natural phytoconstituents—daidzein, resveratrol, and genistein—as dual inhibitors of xanthine oxidase and HMG-CoA reductase through molecular docking studies and to assess their drug-likeness and pharmacokinetic properties using ADME analysis via SwissADME. Methodology: The ligands genistein, resveratrol, and daidzein were directed against the enzymes HMG CoA reductase (PDB ID 416A) and xanthine oxidase (PDB ID 1FO4). Version 1.5.6 of the AUTODOCK VINA tool and BIOVIA Discovery Studio were used for docking simulations. Analysis was done on all of the protein sequences’ amino acid residues and hydrogen bonding interactions. Following the docking method, the phytochemicals were further evaluated utilizing the SwissADME ONLINE program for insilico ADME analysis and drug-like prediction. TSPA (topological polar surface area) and miLogP (molinspiration log P) values were used to test for drug-likeness characteristics. Result Xanthine oxidase produced the best docking simulations with Daidzein (-8.7 kcal/mol), Genistein (-8.4 kcal/mol), and Resveratrol (-7.4 kcal/mol). Similarly, when HMG CoA reductase was the target, Genistein (-8.4 kcal/mol), Daidzein (-7.8 kcal/mol), and Resveratrol (-7.7 kcal/mol) had the best docking scores. Certain phytoconstituents adhere to the drug likeness Log P values and ADME limitations. Conclusion: The molecular docking studies revealed that daidzein, resveratrol, and genistein exhibit strong binding affinities towards xanthine oxidase and HMG-CoA reductase, suggesting their potential as dual inhibitors for managing hyperlipidemia and gout. ADME analysis further confirmed their favorable drug-likeness and pharmacokinetic profiles, highlighting their viability as promising candidates for therapeutic development.

Keywords: Phytoconstituents; xanthine oxidase; HMG CoA reductase; Docking.

[This article belongs to Research and Reviews: A Journal of Pharmaceutical Science ]

How to cite this article:
Mukund DW, Natarajan. K, Vineeth Chandy. Screening of Newer Phytoconstituents on Novel Enzymes for their Biological Activity. Research and Reviews: A Journal of Pharmaceutical Science. 2025; 16(01):81-86.
How to cite this URL:
Mukund DW, Natarajan. K, Vineeth Chandy. Screening of Newer Phytoconstituents on Novel Enzymes for their Biological Activity. Research and Reviews: A Journal of Pharmaceutical Science. 2025; 16(01):81-86. Available from: https://journals.stmjournals.com/rrjops/article=2025/view=203468


References

  1. Lender D, Sysko SK. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Pharmacotherapy. 2006 May;26(5 Pt 2):3S-12S. doi: 10.1592/phco.26.5part2.3S.
  2. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 22; 388(10055):2039-2052. doi: 10.1016/S0140-6736(16)00346-9.
  3. Maiuolo, J., et al. (2016). Oxidative stress in hyperuricemia and associated disease. Frontiers in Bioscience ,2016; 8 :665-675.
  4. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232 (4746):34-47. DOI: 10.1126/science.3513311
  5. Guo J, Suma T, Richardson JJ, Ejima H. Modular assembly of biomaterials using polyphenols as building blocks. ACS Biomaterials Science & Engineering. 2019 Apr 30;5(11):5578-96.
  6. Yamada, A.L.Y.d.S.; Merenda, M.E.Z.; Pereira, L.C.; Bonneti, N.M.D.; Martins, I.d.O.; Komarcheuski, A.S.; Henríquez, L.B.F.; Watanabe, E.K.; Coelho, G.B.C.; Janeiro, V.; et al. Effects of Isoflavone Intake on Energy Requirement, Satiety, and Body Composition of Neutered Adult Cats. Animals202414, 3574. https://doi.org/10.3390/ani14243574
  7. Kassab RB, Elhenawy AA, AbdulrahmanTheyab, Hawsawi YM, Al-Amer OM, Oyouni AAA, Habotta OA, Althagafi HA, Alharthi F, Lokman MS, Alsharif KF, Albrakati A, Al-Ghamdy AO, Elmahallawy EK, Elhefny MA, Hassan KE, Albarakati AJA, Abdel Moneim AE, Moustafa AA. Modulation of inflammatory, oxidative, and apoptotic stresses mediates the renoprotective effect of daidzein against glycerol-induced acute kidney injury in rats. Environ Sci Pollut Res Int. 2023 Dec;30(56):119016-119033. doi: 10.1007/s11356-023-30461-4.
  8. Yang L, Zhao M, Liu M, Zhang W, Zhi S, Qu L, Xiong J, Wang L, Qin C, Nie G. Effects of Genistein on Lipid Metabolism, Antioxidant Activity, and Immunity of Common Carp (Cyprinus carpio L.) Fed with High-Carbohydrate and High-Fat Diets. Aquac Nutr. 2023 Mar 31;2023:9555855. doi: 10.1155/2023/9555855.
  9. Tshibangu JN, Chifundera K, Kaminsky R, Wright AD, König GM. Screening of African medicinal plants for antimicrobial and enzyme inhibitory activity. Journal of Ethnopharmacology. 2002 Apr 1;80(1):25-35. https://doi.org/10.1016/S0378-8741(01)00409-3
  10. Khan A, Unnisa A, Sohel M, Date M, Panpaliya N, Saboo SG, Siddiqui F, Khan S. Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus. In Silico Pharmacol. 2021 Dec 2;10(1):1. doi: 10.1007/s40203-021-00116-8.

Regular Issue Subscription Review Article
Volume 16
Issue 01
Received 04/02/2025
Accepted 03/03/2025
Published 12/03/2025
Publication Time 36 Days


Login


My IP

PlumX Metrics